Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes

ABSTRACTObjective To explore the clinical outcomes and characteristics of TP53-mutated primary myelodysplastic syndromes (MDS).Methods A total of 74 de novo primary MDS patients who were diagnosed and treated in the Department of Hematology of our hospital from January 2018 and September 2021 were a...

Full description

Bibliographic Details
Main Authors:	Lijuan Zhang, Kankan Chen, Yingying Li, Qiuni Chen, Wenting Shi, Tingting Ji, Hong Tao, Zhengmei He, Chunling Wang, Liang Yu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Hematology
Subjects:	Primary myelodysplastic syndromes TP53 mutation mean corpuscular volume prognosis
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2023.2181773

Similar Items

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
by: Fernando Barroso Duarte, et al.
Published: (2017-05-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
by: Čolović Nataša, et al.
Published: (2023-01-01)

TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021-10-01)

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
by: Youshan Zhao, et al.
Published: (2022-06-01)

<i>TP53</i> in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
by: Cosimo Cumbo, et al.
Published: (2020-05-01)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2021-10-01)

<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic Syndromes
by: Mariko Yabe, et al.
Published: (2021-11-01)

<i>TP53</i> Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
by: Heba Alkhatabi, et al.
Published: (2022-03-01)

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes
by: Qiuni Chen, et al.
Published: (2022-04-01)

Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes
by: Qiuni Chen, et al.
Published: (2022-07-01)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
by: Yuxin Wang, et al.
Published: (2022-07-01)

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities
by: Yi Chen, et al.
Published: (2023-11-01)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
by: Chunguang Guo, et al.
Published: (2022-03-01)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
by: Go Omura, et al.
Published: (2017-12-01)

Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
by: Jie Zhou, et al.
Published: (2022-08-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
by: Ziwen Zhang, et al.
Published: (2021-11-01)

TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
by: Shyam A. Patel, et al.
Published: (2023-11-01)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)

Comparative Analysis of Gene Correlation Networks of Breast Cancer Patients Based on Mutations in TP53
by: Byungkyu Park, et al.
Published: (2022-07-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer
by: Feng Zhang, et al.
Published: (2021-05-01)

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Thomas Cluzeau, et al.
Published: (2021-09-01)

RED CELL INDICES IN PATIENTS WITH COVID-19 (AIR HUNGER RED OR NO RED)
by: Maham Arshad, et al.
Published: (2020-09-01)

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer
by: Lanxin Zhang, et al.
Published: (2022-10-01)

Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
by: Fernando Barroso Duarte, et al.
Published: (2014-06-01)

TP53 Mutations in Esophageal Squamous Cell Carcinoma
by: Leqi Zhong, et al.
Published: (2023-09-01)

Evaluation of the sensitivity and specificity of MCH and MCV for screening of Beta thalassemia minor
by: Kaveh Tari, et al.
Published: (2018-12-01)

Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer
by: YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei
Published: (2022-09-01)

Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
by: Dejun Zeng, et al.
Published: (2021-10-01)

Clinical significance of prognostic nutritional index in myelodysplastic syndrome
by: Yue Chen, et al.
Published: (2023-12-01)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
by: Jian Zhang, et al.
Published: (2022-03-01)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
by: Xiang-mei Wen, et al.
Published: (2021-10-01)

TP53 mutations in Romanian patients with colorectal cancer
by: Felix Manirakiza, et al.
Published: (2023-07-01)

Analysis of mutation and promoter methylation of TP53 gene in tumors of the head and neck
by: Jarzynski Adrian, et al.
Published: (2016-06-01)

Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan.
by: Mian Adnan Kakakhel, et al.
Published: (2021-02-01)

The spectrum of TP53 mutations in Rwandan patients with gastric cancer
by: Augustin Nzitakera, et al.
Published: (2024-03-01)

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification
by: Xiaoyi Lin, et al.
Published: (2022-12-01)